UCSF

ZINC03831404

Substance Information

In ZINC since Heavy atoms Benign functionality
September 30th, 2005 24 Yes

Other Names:

"Quinine hydrochloride dihydrate, 99%"

"Quinine sulfate dihydrate, 99%"

(+)-Quinidine

(-)-Quinine

(-)-quinine; (8S,9R)-quinine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4

(-)-Quinine; 130-95-0; C06526; Quinine

(1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol

(3|A,8|A,9r)-6'-methoxycinchonan-9-ol

(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol

(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; sulfuric acid

(8-alpha,9R)-6'-Methoxycinchonan-9-ol

(8.alpha.,9R)-6'-Methoxycinchonan-9-ol

(8alpha,9R)-6'-Methoxycinchonan-9-ol monohydrochloride; 6'-Methoxycinchonan-9-ol monohydrochloride, (8alpha,9R)-; AI3-62121; CCRIS 2002; Chinimetten; Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8-alpha,9R)-; Cinchonan-9-ol, 6'-methoxy-, monohydrochlo

(8S,9R)-6'-Methoxycinchonan-9-ol

(8S,9R)-Quinine

(9R)-6'-methoxy-8alpha-cinchonan-9-ol

(R)-(-)-quinine

(R)-(-)-Quinine, 6-methoxycinchonidine

(R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol

(R)-(6-Methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol hydrochloride

(R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol

(R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

(R)-[(2S,4S,5R)-1-Aza-5-vinylbicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol

(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

(S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol

(S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

.alpha.-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol

12239-42-8

128544-03-6

130-89-2

130-95-0

1407-83-6

145904_ALDRICH

146-40-7; D05681; Quinine ascorbate (USAN)

2-Quinuclidinemethanol, .alpha.-(6-methoxy-4-quinolyl)-5-vinyl-

2-Quinuclidinemethanol, alpha-(6-methoxy-4-quinolyl)-5-vinyl-

21480-31-9

22620_FLUKA

22620_SIGMA

549-56-4

55980-20-6

56-54-2

6'-Methoxycinchonan-9-ol

6'-Methoxycinchonan-9-ol monohydroiodide (8-alpha,9R)-, mixt. with triiodobismuthine; Biioquinol; Bijochinol; Cinchonan-9-ol, 6'-methoxy-, monohydroiodide, (8-alpha,9R)-, mixt. with triiodobismuthine; LS-53756; Quinine bismuth iodide; Quinobine

6'-Methoxycinchonan-9-ol sulfate dihydrate, (8alpha,9R)-, (2:1) (salt); C20H25N2O2; Cinchonan-9-ol, 6'-methoxy-, (8alpha,9R)-, sulfate (2:1) (salt), dihydrate; FEMA No. 2977; LS-176159; Mixture Name; Quinamm; Quinine Sulfate; Quinine Sulfate [USAN:JAN]; Q

6'-Methoxycinchonidine

6'-Methoxycinchonidine;6'-Methoxycinchonine;Quinine sulfate;Quinine sulphate;Quinine, Anhydrous;Quinineanhydrous;Quinoline Alkaloid

6'-Methoxycinchonine

6-Methoxycinchonine

60-93-5; D08461; Quinine (TN); Quinine dihydrochloride

6119-70-6

6119-70-6; Coco-quinine (TN); D02262; Quinine hydrogen sulfate; Quinine sulfate (USP); Quinine sulfate hydrate (JP16)

6183-68-2

6912-57-8

7

72646-90-3

767303-40-2

804-63-7

840482-04-4

857212-53-4

864908-93-0

875538-34-4

888714-03-2

890027-24-4

894767-09-0

898813-59-7

898814-28-3

899813-83-3

900786-66-5

900789-95-9

906550-97-8

909263-47-4

909767-48-2

909882-78-6

910878-25-0

910880-97-6

911445-75-5

918778-04-8

AC1L1ANE

AC1L1R7Y

AC1L9AHT

AC1LCUGN

AC1MHWS7

AC1MI1Q5

AC1Q4EZ5

AC1Q58AF

Aflukin

AR-1A4833

AR-1H2065

BB_NC-0697

beta-Quinine

Biquinate (*Bisulfate heptathydrate*)

C06526

C20H24N2O2

C20H24N2O2.7H2O.H2O4S; Cinchonan-9-ol, 6'-methoxy-, (8-alpha,9R)-, sulfate (1:1) (salt), heptahydrate; LS-141258; Quinine bisulfate heptahydrate; Quinine sulfate heptahydrate; Quinine, sulfate (1:1) (salt), heptahydrate

CCRIS 5755

CHEBI:111177

CHEBI:15001; CHEBI:569215; CHEBI:602929; CHEBI:127176; CHEBI:355947; CHEBI:8723; CHEBI:26499

CHEBI:15854

CHEMBL170

CHEMBL97

Chinin

Chinin [German]

Chinine

chininum

CID1065

CID3034034

CID3036746

CID441073

CID637552

CID8549

Cin-Quin

Cinchonan-9-ol, 6'-methoxy-

Cinchonan-9-ol, 6'-methoxy-, (8-alpha,9R)-

Cinchonan-9-ol, 6'-methoxy-, (8-alpha,9R)-, L-aspartate (1:2) (salt); Diaspartate de quinine [French]; L-Aspartic acid, compd. with (8-alpha,9R)-6'-methoxycinchonan-9-ol (2:1); LS-22118; Quinine L-aspartate (1:2) (salt)

Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-

Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate

Cinchonan-9-ol, 6'-methoxy-, (8alpha,9R)-

Cinchonan-9-ol, 6'-methoxy-, (9S)-

Coco-Quinine

Conchinin

Conquinine

D08460

DAP000491

DB00468

Dentojel (*Bisulfate heptathydrate*)

EINECS 205-003-2

EINECS 215-805-4

FDA

GNF-Pf-506

HMS1607A11

HMS1791J11

HMS2089E05

HSDB 2501

I14-3348

I14-3397

IBS-L0034250

InChI=1/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H

JAN

Kinder Quinina

Kinder Quinina (TN)

KST-1A1085

L001278

LS-141252

LS-194958

LS-4562

LT00645788

MFCD00078498

MFCD00078499

MFCD00150790

MFCD00150792

MFCD00151247

MFCD00151248

MFCD00198096

MFCD02685487

MFCD03939177

MFCD03939586

MFCD03940719

MFCD07808735

MFCD09866186

MFCD09867795

MI

MLS001304041

MolPort-000-146-082

MolPort-001-766-747

MolPort-002-507-196

MolPort-003-901-021

N/A

NCGC00015871-03

NCGC00142453-01

NCGC00159499-02

NCGC00159499-03

NCGC00162322-01

NCGC00162322-02

NCGC00163142-03

NCGC00166281-01

nchem.1039-compI

nchem.180-comp1a

nchembio.215-comp5

nchembio.368-comp9

nchembio.87-comp19

NCI60_004320

NF); Quinine Ascorbate (USAN); Quinine Phosphate (NF); Quinine Bisulfate (MI

NF); Quinine Bisulfate (MI

NF); Quinine Dihydrochloride (MI

NF); Quinine Glycerophosphate (NF)

NF); Quinine Glycerophosphate (NF); Quinine Hydrobromide (MI

NF); Quinine Hydrobromide (MI

NF); Quinine Hydrochloride (JAN

NF); Quinine Phosphate (NF); Quinine Ascorbate (USAN); Quinine Dihydrochloride (MI

NF); Quinine Salicylate (MI

NF); Quinine Sulfate (FDA

NF); Quinine Sulfate (JAN

NSC 192949

NSC 5362

NSC131458

NSC192949

NSC5362

NSC667852

Q0028

QA-6911

Quinamm (*2:1 Sulfate salt*), dihydrate

Quindan

Quine (*2:1 Sulfate salt*, dihydrate)

Quinidex

quinidine

Quinidine ,Quinine bisulfate

quinidinehydrochloridemonohydrate

Quinimax

quinina

Quinine (BAN

Quinine (BAN)

Quinine anhydrous

QUININE ANHYDROUS, FOR FLUORESCENCE

QUININE ANHYDROUS, FOR FLUORESCENCE, 98.0%+

Quinine bisulfate

Quinine bisulfate; Quinine hydrogen sulfate; Quinine sulfate (2:1); Quinine sulfate anhydrous

Quinine Dab

Quinine dihydrochloride

Quinine HCl

Quinine hemisulfate monohydrate

Quinine hemisulfate monohydrate, 99%

Quinine hydroChloride

Quinine hydrochloride dihydrate

Quinine hydrogen sulphate

QUININE MONO HCL

Quinine monohydrochloride dihydrate

Quinine monohydrochloride dihydrate, 99% (total base), may contain up to 10% Dihydroquinine

QUININE SULFATE

Quinine sulfate (2:1) (salt) dihydrate

Quinine sulfate dihydrate

Quinine sulfate dihydrate, specified according to the requirements of USP

Quinine sulfate salt monohydrate

Quinine sulphate

Quinine [BAN]

quinine(1+)

Quinine, 99%, anhydrous

Quinine, Anhydrous

Quinine, hydrobromide, hydrate; 4-Quinolinemethanol, 6-methoxy-.alpha.-5-vinyl-2-quinuclidinyl hydrobromide

Quinine, polymers

Quinine, tannate

Quinineanhydrous

QUININEHCL

Quinoline Alkaloid

Quinora

Quinsan (*2:1 Sulfate salt*), dihydrate

Quniacridine

SB01652

SMR000718748

ST056282

TCMDC-123484

TCMDC-123939

TCMDC-125479

UNII-A7V27PHC7A

USP)

USP); Quinine HCl (JAN

WLN: T66 BNJ HO1 EYQ-DT66 A B CNTJ A1U1

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.06 7.18 -40.05 2 4 1 47 325.432 4
Lo Low (pH 4.5-6) 3.06 7.62 -89.58 3 4 2 48 326.44 4

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 5.444 Bitter DB
Mp [°C] 176 - 177 Acros Organics
MP 177 TCI
Melting_Point 217-218? dec. Alfa-Aesar
Melting_Point 217-218° dec. Alfa-Aesar
ALOGPS_SOLUBILITY 3.34e-01 g/l DrugBank-approved
Purity 95% Fluorochem
Purity 99% APIChem
Target Beta-glucuronidase(P08236)&Pyruvate kinase isozymes R/L(P30613)&Glutathione S-transferase P(P09211)&Neutrophil cytosol factor 1(P14598)&Transcription factor p65(Q04206)&Golgi-associated plant pathogenesis-related protein 1(Q9H4G4)&Membrane primary amine o Herbal Ingredients Targets
UniProt Database Links CP3A4_HUMAN; GNAT3_BOVIN; GNAT3_MOUSE; GNAT3_RAT; GR33A_DROME; NAOX_LACLM; NHX1_ARATH; S22A1_BOVIN; S22A1_HUMAN; S22A1_MOUSE; S22A1_PIG; S22A1_RABIT; S22A1_RAT; SL9A7_HUMAN; TPO4_YEAST ChEBI
PUBCHEM_PATENT_ID EP0000009A1; EP0000291A1; EP0000302A1; EP0001108A1; EP0001796A1; EP0004904A1; EP0007116A1; EP0007996A1; EP0008833A1; EP0009560A1; EP0010316A1; EP0010409A1; EP0010410A2; EP0010739A1; EP0013560A1; EP0013561A1; EP0014929A1; EP0017080A2; EP0017705A1; EP001790 IBM Patent Data
PUBCHEM_PATENT_ID EP0148811A1; EP0293347A1; EP0293347B1; EP0326278A1; EP0351897A2; EP0371493A1; EP0371493B1; US3965256; US4189426; US4235870; US4780318; US5001161; US5081154; US5174998; US6099864; WO1989012391A1; WO1999059554A1 IBM Patent Data
Patent Database Links EP1489070; EP1533300; EP1602926; EP1700601; EP1743892; EP1746090; EP1780203; EP1808173; EP1815846; EP1829527; EP1829528; EP1878445; EP1891958; EP1923702; EP1990346; US2002107266; US2002147238; US2004019111; US2005038024; US2005065213; US2005075338; US2005 ChEBI
H phrase H302: Harmful if swallowed; H312: Harmful in contact with skin; H332: Harmful if inhaled; H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation Acros Organics
H phrase H315: Causes skin irritation Acros Organics
H phrase H315: Causes skin irritation; H319: Causes serious eye irritation; H302: Harmful if swallowed; H335: May cause respiratory irritation; H317: May cause an allergic skin reaction; H334: May cause allergy or asthma symptoms or breathing difficulties if inhal Acros Organics
Target Others Selleck Chemicals
P phrase P261: Avoid breathing dust/fume/gas/mist/vapors/spray Acros Organics
P phrase P261: Avoid breathing dust/fume/gas/mist/vapors/spray; P280: Wear eye protection/face protection Acros Organics
P phrase P261: Avoid breathing dust/fume/gas/mist/vapors/spray; P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell; P302+ P352: IF ON SKIN: Wash with plenty of soap and water; P280: Wear protective gloves/protective clothing/eye Acros Organics
Target Potassium Channel Selleck Chemicals
R phrase R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.; R36/37/38: Irritating to eyes, respiratory system and skin. Acros Organics
R phrase R22: Harmful if swallowed. Acros Organics
R phrase R22: Harmful if swallowed.; R36/37/38: Irritating to eyes, respiratory system and skin.; R42/43: May cause sensitisation by inhalation and skin contact. Acros Organics
Reactome Database Links REACT_15538; REACT_163726; REACT_22221; REACT_22239; REACT_22289; REACT_22348 ChEBI
S phrase S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Acros Organics
PUBCHEM_PATENT_ID US5968867 IBM Patent Data
Hazard XN: Harmful Acros Organics

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
SCN1A-1-E Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 4400 0.31 Binding ≤ 10μM
SCN2A-2-E Sodium Channel Protein Type II Alpha Subunit (cluster #2 Of 2), Eukaryotic Eukaryotes 4400 0.31 Binding ≤ 10μM
SCN3A-1-E Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 4400 0.31 Binding ≤ 10μM
SCN8A-1-E Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 4400 0.31 Binding ≤ 10μM
CP2D6-1-E Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic Eukaryotes 610 0.36 ADME/T ≤ 10μM
CP2DI-1-E Cytochrome P450 2D18 (cluster #1 Of 1), Eukaryotic Eukaryotes 1700 0.34 ADME/T ≤ 10μM
CP2DQ-1-E Cytochrome P450 2D2 (cluster #1 Of 1), Eukaryotic Eukaryotes 94 0.41 ADME/T ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 652 0.36 Functional ≤ 10μM
Z50426-6-O Plasmodium Falciparum (isolate K1 / Thailand) (cluster #6 Of 9), Other Other 81 0.41 Functional ≤ 10μM
Z50460-2-O Leishmania Major (cluster #2 Of 4), Other Other 9530 0.29 Functional ≤ 10μM
Z81138-1-O ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other Other 10000 0.29 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
SCN1A_HUMAN P35498 Sodium Channel Protein Type I Alpha Subunit, Human 4400 0.31 Binding ≤ 10μM
SCN2A_HUMAN Q99250 Sodium Channel Protein Type II Alpha Subunit, Human 4400 0.31 Binding ≤ 10μM
SCN3A_HUMAN Q9NY46 Sodium Channel Protein Type III Alpha Subunit, Human 4400 0.31 Binding ≤ 10μM
SCN8A_HUMAN Q9UQD0 Sodium Channel Protein Type VIII Alpha Subunit, Human 4400 0.31 Binding ≤ 10μM
Z50460 Z50460 Leishmania Major 9410 0.29 Functional ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 100 0.41 Functional ≤ 10μM
Z50426 Z50426 Plasmodium Falciparum (isolate K1 / Thailand) 12 0.46 Functional ≤ 10μM
Z81138 Z81138 ScN2a (Scrapie-infected Neuroblastoma Cells) 10000 0.29 Functional ≤ 10μM
CP2DI_RAT Q64680 Cytochrome P450 2D18, Rat 1700 0.34 ADME/T ≤ 10μM
CP2DQ_RAT P10634 Cytochrome P450 2D2, Rat 94 0.41 ADME/T ≤ 10μM
CP2D6_HUMAN P10635 Cytochrome P450 2D6, Human 1800 0.34 ADME/T ≤ 10μM

Direct Reactome Annotations (via ChEBI)

Description Species
Class C/3 (Metabotropic glutamate/pheromone receptors)
G alpha (i) signalling events
Organic cation transport

Reactome Annotations from Targets (via Uniprot)

Description Species
CYP2E1 reactions
Fatty acids
Interaction between L1 and Ankyrins
Miscellaneous substrates
Xenobiotics

Analogs ( Draw Identity 99% 90% 80% 70% )